Alzheimer’s Drug Market To Top $10B By 2021
The market is expected to by a compound annual growth rate of 11%.
The market is expected to by a compound annual growth rate of 11%.
Researchers set out to examine the idea that past experience with an object alters the brain circuitry responsible for object recognition.
New research questions the efficacy of metyrapone as an adjunctive treatment for treatment-resistant depression.
The $1.1 billion figure is on top of the $400 million already included in the December budget agreement.
In a mouse model of schizophrenia, the rodents’ brains showed a significant decrease in inhibitory CA2 neurons.
New onset of depression is associated with longer duration of opioid use.
After one month of transcendental meditation, more than 80% of active-duty soldiers with PTSD had stabilized, reduced, or stopped taking meds.
China’s U.N. delegation has argued that ketamine is a health risk when it is used in a recreational fashion.
Nerve cells from Rett Syndrome patients saw increased levels of an important molecule critical for neurotransmitter functioning after being given IGF1.
Obama has proposed a $500 million investment to improve access to mental health care as part of gun control reform.